this post was submitted on 08 Dec 2023
151 points (100.0% liked)

Interesting Global News

2653 readers
1132 users here now

What is global news?

Something that happened or was uncovered recently anywhere in the world. It doesn't have to have global implications. Just has to be informative in some way.


Post guidelines

Title formatPost title should mirror the news source title.
URL formatPost URL should be the original link to the article (even if paywalled) and archived copies left in the body. It allows avoiding duplicate posts when cross-posting.
[Opinion] prefixOpinion (op-ed) articles must use [Opinion] prefix before the title.


Rules

1. English onlyTitle and associated content has to be in English.
2. No social media postsAvoid all social media posts. Try searching for a source that has a written article or transcription on the subject.
3. Respectful communicationAll communication has to be respectful of differing opinions, viewpoints, and experiences.
4. InclusivityEveryone is welcome here regardless of age, body size, visible or invisible disability, ethnicity, sex characteristics, gender identity and expression, education, socio-economic status, nationality, personal appearance, race, caste, color, religion, or sexual identity and orientation.
5. Ad hominem attacksAny kind of personal attacks are expressly forbidden. If you can't argue your position without attacking a person's character, you already lost the argument.
6. Off-topic tangentsStay on topic. Keep it relevant.
7. Instance rules may applyIf something is not covered by community rules, but are against lemmy.zip instance rules, they will be enforced.


Companion communities

Icon attribution | Banner attribution

founded 1 year ago
MODERATORS
 

cross-posted from: https://lemmy.world/post/9298788

The Biden Administration on Thursday announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.

The policy creates a roadmap for the government's so-called march-in rights, which have never been used before. They would allow the government to grant additional licenses to third parties for products developed using federal funds if the original patent holder does not make them available to the public on reasonable terms.

Under the draft roadmap, seen by Reuters, the government will consider factors including whether only a narrow set of patients can afford the drug, and whether drugmakers are exploiting a health or safety issue by hiking prices.

"We'll make it clear that when drug companies won't sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less," White House adviser Lael Brainard said on a press call.

you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 3 points 11 months ago

A good analysis would be to determine what portion of the drug market would fall in this category. I imagine the amount of drug R&D done with some amount of federal dollars is pretty high.

If this policy has enough teeth to scare pharma corps, then it will probably change their behaviors. They could decide that they need to use minimal federal funding which could slow drug development. I wonder if this policy (or others) is meant to address this potential.